Lakefront Biotherapeutics NV
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| GLPGF | BHVN | SLS | IOVA | 0A3M.IL | LEGN | |
|---|---|---|---|---|---|---|
| Market cap | 2.11B | 2.21B | 1.74B | 3.85B | 25.02B | 4.60B |
| P/E (TTM) | 3.0 | — | — | — | 5.1 | — |
| Forward P/E | — | -7.8 | -86.0 | -43.4 | 5.0 | 22.5 |
| Price/book | 0.6 | -22.5 | 12.6 | 5.2 | 1.1 | 3.7 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −4.48% | +78.66% | +464.20% | +276.62% | −13.17% | −29.66% |
| Today | 0.00% | −4.04% | −5.91% | −2.24% | +2.19% | +3.82% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All GLPGF news ›Analysts Have Conflicting Sentiments on These Healthcare Companies: Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR)
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Lakefront Biotherapeutics (LKFT), Prime Medicine, Inc. (PRME) and Electrocore (ECOR). Morgan Stanley analyst Judah Frommer maintained a Hold rating on…
Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT) Stock Now Rated “Hold” by Wall Street Brokerages
Posted by Defense World Staff on Oct 25th, 2026 View Our Latest Stock Analysis on Lakefront Biotherapeutics American Depositary Shares LKFT stock opened at $31.65 on Friday. The company has a market capitalization of $2.09 billion, a PE…
Critical Analysis: Protagonist Therapeutics (NASDAQ:PTGX) & Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT)
Posted by Defense World Staff on Oct 25th, 2026 Lakefront Biotherapeutics American Depositary Shares (NASDAQ:LKFT – Get Free Report) and Protagonist Therapeutics (NASDAQ:PTGX – Get Free Report) are both mid-cap healthcare companies, but…
Lakefront Biotherapeutics buys back €2.85M in shares
Lakefront held 1,985,157 of its own ordinary shares as of October 16, 2026, after completing the repurchase program. Lakefront Biotherapeutics NV repurchased 107,804 shares between October 12 and October 16, 2026, for a total of…
Lakefront Biotherapeutics Discloses Bank of America Stake Cut Below 10% Threshold
Lakefront Biotherapeutics ( (LKFT) ) has issued an announcement. On October 8, 2026, Lakefront Biotherapeutics reported that it had received a transparency notification under Belgian disclosure rules from Bank of America Corporation. The…
More from 1 other outlet
Lakefront Biotherapeutics Autoimmune Disorder Pemphigus Treatment Gets FDA Orphan Drug Designation
Published on 08/24/2026 at 04:43 pm EDT - Modified on 08/24/2026 at 04:44 pm EDT A Lakefront Biotherapeutics treatment for the autoimmune disorder pemphigus received orphan drug designation from the Food and Drug Administration. The…
Tranche Update on Lakefront Biotherapeutics NV's Equity Buyback Plan announced on June 9, 2026.
From June 9, 2026 to August 26, 2026, the company has repurchased 916,057 shares, representing 1.39% for ?22.9 million. With this, the company has completed the repurchase of 916,057 shares,... Published on 08/12/2026 at 07:58 am EDT -…
Lakefront Biotherapeutics NV commences an Equity Buyback for 10% of its issued share capital, under the authorization approved on April 28, 2026.
Lakefront Biotherapeutics NV commences share repurchases on June 9, 2026, under the program mandated by the shareholders in the Extraordinary General Meeting held on April 28, 2026. As per the... Lakefront Biotherapeutics NV (ENXTAM:LKFT)…
Total current assets of Lakefront Biotherapeutics – XETR:GXE
Lakefront Biotherapeutics is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. Its clinical pipeline includes filgotinib, GLP3667, Toledo program, and idiopathic…
Lakefront Biotherapeutics' Gamgertamig Has Meaningful Opportunity in Rare Autoimmune Diseases, RBC Says
Lakefront Biotherapeutics has a meaningful opportunity with its asset gamgertamig for the treatment of rare autoimmune diseases, RBC Capital Markets said in a note Wednesday. Gamgertamig has... Biotechnology & Medical Research Lakefront…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- marketscreener.com14
- defenseworld.net2
- stocktitan.net2
- markets.businessinsider.com1
- theglobeandmail.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 22 articles, not a forecast.